Explore WARF Inventions and Patents
WARF’s portfolio of more than 1,500 patented technologies covers a wide range of categories, including analytical instrumentation, pharmaceuticals, food products, agriculture, research tools, medical devices, pluripotent stem cells, clean technology, information technology and semiconductors.
Information summaries, which describe each technology and its applications, benefits, inventors and patent status, can be downloaded, printed and shared by clicking on the technology category links to the left on this page.
In the process, a fresh or frozen sample is stained with DNA-binding fluorescent dye and imaged with a microscope. The brightness of the sperm head is averaged and compared with samples of known fertility.
The gel can contain a combination of therapeutic agents like rapamycin, paclitaxel and 17-AAG. After being administered to a patient, the gel releases the drugs at a controlled rate, and then biodegrades into nontoxic fragments.
Drug-eluting stents and other medical devices containing idarubicin (or an analog) could be administered prior to or following a vascular procedure like angioplasty.
The researchers previously described their ‘recycling’ method for use with aromatic compounds. Now, they have rendered the process enantioselective using an asymmetric bidentate phosphine ligand to produce scaffolds with high enantiomeric purity.
In essence, the use of the phosphine ligand helps form a chiral center in a complex product that is otherwise costly or impossible to create.
A membrane preparation containing the protein of interest is treated with TFA to achieve protein extraction and solubilization. The TFAs can contain a pair of maltose-functionalized deoxycholate units that are long enough to match the width of a lipid bilayer and form a sheath around the protein’s nonpolar surfaces. The TFAs can stabilize intrinsic membrane proteins in native-like conformations.